Aimovig 140 mg

Aimovig 140 mg is a subcutaneous solution containing erenumab for migraine prevention. This medication is designed to help reduce the frequency and severity of migraines in adults. Learn more about its uses and effects.

Aimovig 140 mg is primarily used for migraine prevention. It is a calcitonin gene-related peptide (CGRP) antagonist, which works by targeting specific pathways involved in migraine attacks. People often ask, 'What is Aimovig used for?' and the answer is that it is intended for those who experience frequent migraines and are looking for a preventive treatment option.

Common effects of Aimovig 140 mg may include injection site reactions, such as redness, pain, or swelling. Some users might also experience constipation, muscle tension, or fatigue. These effects vary among individuals and are not experienced by everyone who uses the medication.

Aimovig 140 mg should be used with caution in individuals with a history of allergic reactions to erenumab or any of its components. It is important to follow the prescribed administration guidelines and consult a healthcare provider before starting this treatment. Always store the solution properly to maintain its efficacy.

Aimovig 140 mg may interact with other medications, including those that affect the immune system or blood pressure. It is advisable to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.